These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 18728494)

  • 41. Prevention of Glutamate Accumulation and Upregulation of Phospho-Akt may Account for Neuroprotection Afforded by Bergamot Essential Oil against Brain Injury Induced by Focal Cerebral Ischemia in Rat.
    Amantea D; Fratto V; Maida S; Rotiroti D; Ragusa S; Nappi G; Bagetta G; Corasaniti MT
    Int Rev Neurobiol; 2009; 85():389-405. PubMed ID: 19607983
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neuroprotective profile of novel SRC kinase inhibitors in rodent models of cerebral ischemia.
    Liang S; Pong K; Gonzales C; Chen Y; Ling HP; Mark RJ; Boschelli F; Boschelli DH; Ye F; Barrios Sosa AC; Mansour TS; Frost P; Wood A; Pangalos MN; Zaleska MM
    J Pharmacol Exp Ther; 2009 Dec; 331(3):827-35. PubMed ID: 19741150
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Endogenous brain protection by granulocyte-colony stimulating factor after ischemic stroke.
    Sevimli S; Diederich K; Strecker JK; Schilling M; Klocke R; Nikol S; Kirsch F; Schneider A; Schäbitz WR
    Exp Neurol; 2009 Jun; 217(2):328-35. PubMed ID: 19332060
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Doxycycline inhibits matrix metalloproteinase-9 and laminin degradation after transient global cerebral ischemia.
    Lee H; Park JW; Kim SP; Lo EH; Lee SR
    Neurobiol Dis; 2009 May; 34(2):189-98. PubMed ID: 19200854
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Melatonin reduces experimental subarachnoid hemorrhage-induced oxidative brain damage and neurological symptoms.
    Ersahin M; Toklu HZ; Cetinel S; Yüksel M; Yeğen BC; Sener G
    J Pineal Res; 2009 Apr; 46(3):324-32. PubMed ID: 19215574
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pentoxifylline treatment improves neurological and neurochemical deficits in rats subjected to transient brain ischemia.
    Bruno Rde B; Marques TF; Batista TM; Lima JC; de Arruda KG; Lima PF; Santos Nda S; Cunha GM; Vitor HV; Viana GS
    Brain Res; 2009 Mar; 1260():55-64. PubMed ID: 19161991
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neuroprotective effects of the survival promoting peptide Y-P30.
    Schneeberg J; Riek-Burchardt M; Braun H; Landgraf P; Kreutz MR; Reymann KG
    Eur J Pharmacol; 2009 Aug; 616(1-3):81-5. PubMed ID: 19490911
    [TBL] [Abstract][Full Text] [Related]  

  • 48. (-)Deprenyl-N-oxide, a (-)deprenyl metabolite, is cytoprotective after hypoxic injury in PC12 cells, or after transient brain ischemia in gerbils.
    Szilágyi G; Simon L; Wappler E; Magyar K; Nagy Z
    J Neurol Sci; 2009 Aug; 283(1-2):182-6. PubMed ID: 19332347
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Opioid effects of psychotropic analgesic nitrous oxide on the dopaminergic system.
    Gillman MA; Lichtigfeld FJ
    Anesth Analg; 1995 Apr; 80(4):855-6. PubMed ID: 7893062
    [No Abstract]   [Full Text] [Related]  

  • 50. Dissociating the effects of nitrous oxide on brain electrical activity using fixed order time series modeling.
    Liley DT; Leslie K; Sinclair NC; Feckie M
    Comput Biol Med; 2008 Oct; 38(10):1121-30. PubMed ID: 18834978
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Statins and stroke.
    Rodríguez-Yáñez M; Agulla J; Rodríguez-González R; Sobrino T; Castillo J
    Ther Adv Cardiovasc Dis; 2008 Jun; 2(3):157-66. PubMed ID: 19124419
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Minocycline: a neuroprotective agent for hypoxic-ischemic brain injury in the neonate?
    Buller KM; Carty ML; Reinebrant HE; Wixey JA
    J Neurosci Res; 2009 Feb; 87(3):599-608. PubMed ID: 18831005
    [TBL] [Abstract][Full Text] [Related]  

  • 53. No magic bullets: the ephemeral nature of anesthetic-mediated neuroprotection.
    Patel P
    Anesthesiology; 2004 May; 100(5):1049-51. PubMed ID: 15114198
    [No Abstract]   [Full Text] [Related]  

  • 54. Neuropharmacological and pharmacokinetic properties of berberine: a review of recent research.
    Ye M; Fu S; Pi R; He F
    J Pharm Pharmacol; 2009 Jul; 61(7):831-7. PubMed ID: 19589224
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Possible mechanisms of pharmacological neuronal protection.
    Cottrell JE
    J Neurosurg Anesthesiol; 1995 Jan; 7(1):31-7. PubMed ID: 7533567
    [No Abstract]   [Full Text] [Related]  

  • 56. Neuroprotective effect of hydroxytyrosol and hydroxytyrosol acetate in rat brain slices subjected to hypoxia-reoxygenation.
    González-Correa JA; Navas MD; Lopez-Villodres JA; Trujillo M; Espartero JL; De La Cruz JP
    Neurosci Lett; 2008 Dec; 446(2-3):143-6. PubMed ID: 18809463
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Neuroprotection against cerebral ischemia. A review of animal studies and correlation with human trial results.
    Jonas S; Ayigari V; Viera D; Waterman P
    Ann N Y Acad Sci; 1999; 890():2-3. PubMed ID: 10668409
    [No Abstract]   [Full Text] [Related]  

  • 58. Selective adenosine A2a receptor antagonism reduces JNK activation in oligodendrocytes after cerebral ischaemia.
    Melani A; Cipriani S; Vannucchi MG; Nosi D; Donati C; Bruni P; Giovannini MG; Pedata F
    Brain; 2009 Jun; 132(Pt 6):1480-95. PubMed ID: 19359287
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Injury and repair mechanisms in ischemic stroke: considerations for the development of novel neurotherapeutics.
    Candelario-Jalil E
    Curr Opin Investig Drugs; 2009 Jul; 10(7):644-54. PubMed ID: 19579170
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Nitrous oxide. Neurological, circulatory and cellular effects].
    Novelli GP; Casali R; De Gaudio AR; Del Mese A; Falchi S; Festimanni F; Minoni C; Peduto VA; Pieraccioli E; Piscitelli P
    Minerva Anestesiol; 1981 Sep; 47(9):565-644. PubMed ID: 7031508
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.